Cancer NanoHerb: Plant-based nanoformulas for cancer patients

Cancer NanoHerb: Plant-based nanoformulas for cancer patients

Team Members

PI: Associate Professor Andreas Charalambous, Department of Nursing, Faculty of Health Sciences, Cyprus University of Technology
PhD Student, Maria Dolores Christofi, Department of Nursing, Faculty of Health Sciences, Cyprus University of Technology

Cancer NanoHerb is in its first cycle at Cyprus Seeds. It addresses the symptoms and side effects caused by chemotherapy and radiation treatment for cancer patients which eventually reduce in the quality of life of the patient. The technology of Cancer NanoHerb will provide cancer patients with all-natural bioactive ingredient oral formulas, incorporating nanotechnology-based drug delivery systems. These nanoformulations are specifically targeted for the supportive and integrative care of cancer patients, providing the tools to help them withstand the strain of conventional treatment and improve the patient reported outcomes, including their quality of life and treatment experience.